TEKIMFI Trademark

Trademark Overview

On Monday, June 28, 2021, a trademark application was filed for TEKIMFI with the United States Patent and Trademark Office. The USPTO has given the TEKIMFI trademark a serial number of 90798804. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, March 25, 2025. This trademark is owned by Johnson & Johnson. The TEKIMFI trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
tekimfi

General Information

Serial Number90798804
Word MarkTEKIMFI
Filing DateMonday, June 28, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 1, 2021NEW APPLICATION ENTERED
Friday, September 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 8, 2022ASSIGNED TO EXAMINER
Thursday, March 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 1, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 1, 2022SOU EXTENSION 1 FILED
Thursday, December 1, 2022SOU EXTENSION 1 GRANTED
Tuesday, December 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 25, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 25, 2023SOU EXTENSION 2 FILED
Thursday, May 25, 2023SOU EXTENSION 2 GRANTED
Saturday, May 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023SOU EXTENSION 3 FILED
Wednesday, November 29, 2023SOU EXTENSION 3 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2024SOU EXTENSION 4 FILED
Thursday, May 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2024SOU EXTENSION 5 FILED
Monday, November 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 25, 2025SOU EXTENSION 5 GRANTED
Tuesday, March 25, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2024SOU EXTENSION 4 GRANTED
Wednesday, May 22, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

tekimfi diseases anti system metabolic oncologic ophthalmic related intestinal infectious respiratory